Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

14,520 studies for “lung cancer”

A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)Active Not Recruiting
NCT06687369Phase 3Updated Sep 10, 2026
Sponsor: mAbxience Research S.L.
Non Squamous Non Small Cell Lung Cancer
Armenia, Bosnia and Herzegovina, Brazil, Georgia, Greece +19 more
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung CarcinomaSuspended
NCT06014827Phase 2Updated Sep 10, 2026
Sponsor: City of Hope Medical Center
Lung Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Increasing Equity in Lung Cancer ScreeningRecruiting
NCT06360822NAUpdated Sep 10, 2026
Sponsor: Indiana University
Lung Cancer
United States
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCRecruiting
NCT07462377Phase 1Updated Sep 10, 2026
Sponsor: EpiBiologics
Epidermal Growth Factor · Epidermal Growth Factor Receptor · Epidermal Growth Factor Receptor Gene Mutation · Non Small Cell
United States
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerActive Not Recruiting
NCT04514497Phase 1Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Lung Small Cell Carcinoma · Metastatic Malignant Solid Neoplasm · Metastatic Neuroendocrine Carcinoma · Metastatic Pancreatic Adenocarcinoma
United States
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Active Not Recruiting
NCT05557045Phase 1Updated Sep 10, 2026
Sponsor: Jazz Pharmaceuticals
Advanced Cancer · Metastatic Cancer · Solid Tumor · Melanoma
United States
Right Ventricular Afterload Indices in Lung SurgeryNot Yet Recruiting
NCT07812207N/AUpdated Sep 10, 2026
Sponsor: University of Glasgow
Lung Cancer (Suspected or Confirmed) · Thoracoscopic Lobectomy · One Lung Ventillation (OLV)
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerRecruiting
NCT04181060Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8
United States
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Recruiting
NCT06452277Phase 3Updated Sep 10, 2026
Sponsor: Bayer
Advanced Non-small Cell Lung Cancer, HER2 Mutation
United States, Argentina, Australia, Austria, Belgium +31 more
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerRecruiting
NCT06287775Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Extensive Stage Lung Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Role of Genetic Factors in the Development of Lung DiseaseRecruiting
NCT00001532N/AUpdated Sep 10, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis · Asthma
United States
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) ParticipantsActive Not Recruiting
NCT06269133N/AUpdated Sep 10, 2026
Sponsor: Regeneron Pharmaceuticals
Advanced Non-small Cell Lung Cancer
United States
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung CancerRecruiting
NCT07659782Phase 2Updated Sep 10, 2026
Sponsor: Verastem, Inc.
Non-Small Cell Lung Cancer
United States, Australia
A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in Patients With Locally Advanced, Unresectable EGFR-mutated Non-small Cell Lung Cancer(Stage III) Whose Disease Has Not Progressed Following Definitive Platinum-based Chemoradiation Therapy(PANKU-Lung08)Recruiting
NCT07640789Phase 3Updated Sep 10, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Non-small Cell Lung Cancer Stage III
China
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerActive Not Recruiting
NCT04310007Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI TreatmentRecruiting
NCT06830694Phase 2Updated Sep 10, 2026
Sponsor: Sehhoon Park
Small Cell Carcinoma of Lung
South Korea
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and EtoposideCompleted
NCT00632853Phase 3Updated Sep 10, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Lung Cancer
United States, Israel, Puerto Rico, South Korea
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)Not Yet Recruiting
NCT07602855Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: GlaxoSmithKline
Neoplasms, Lung
Japan
COVID-19 Experiences in the SELF CohortCompleted
NCT05369611N/AUpdated Sep 10, 2026
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
COVID-19
United States
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialRecruiting
NCT06498635Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States
Percutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and Lung Oligometastases: A Safety and Efficacy StudyNot Yet Recruiting
NCT07799194NAUpdated Sep 10, 2026
Sponsor: Energenx Medical LTD.
Lung Cancer (NSCLC)
China
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsRecruiting
NCT06914128Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Bayer
MTAP-deleted Solid Tumors
United States, Australia, Belgium, China, Czechia +8 more
A Study of KK2269 in Adult Participants With Solid TumorsRecruiting
NCT06266299Phase 1Updated Sep 10, 2026
Sponsor: Kyowa Kirin Co., Ltd.
Advanced Solid Tumor · Metastatic Solid Tumor · Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma
United States, Japan
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruiting
NCT06293898Phase 1Updated Sep 10, 2026
Sponsor: SystImmune Inc.
Endometrial Cancer · Cervical Cancer · Ovarian Cancer · Urothelial Carcinoma
United States
AP-L1898 Capsule in Patients With Non-small Cell Lung CancerTerminated
NCT04993391Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Suzhou Junjing BioSciences Co., Ltd.
Lung Cancer
China

14,520 studies found